[144] N-able, Inc. SEC Filing

Rhea-AI Filing Summary

N-able, Inc. (NABL) Form 144 notice reports a proposed sale of 34,568 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $266,190.88. The filing lists the shares as previously received as restricted stock in four tranches between 11/03/2022 and 05/21/2024, totaling the 34,568 shares to be sold. The company has 187,096,094 shares outstanding, and no securities were reported sold by the filer in the past three months. The filer certifies they are unaware of any undisclosed material adverse information and references Rule 144 and potential 10b5-1 plans.

Positive

• Full disclosure of broker, share count, and acquisition history enables investor transparency
• Filer certifies no undisclosed material adverse information, reducing informational asymmetry
• No reported sales in the past three months, limiting near-term insider selling pressure

Negative

• Insider proposes to sell 34,568 shares, which could be perceived negatively by some investors despite small size
• Aggregate market value $266,190.88 indicates a non-zero liquidity event by an insider

Insights

Securities Analyst

TL;DR: Routine insider notice for a modest proposed sale; not material to capitalization.

The filer intends to sell 34,568 shares valued at $266,190.88 via Morgan Stanley on the NYSE. Compared with the reported 187,096,094 shares outstanding, this sale represents a very small fraction of total equity, indicating limited dilution or market impact. The securities were acquired as restricted stock across four dates, consistent with compensation vesting. The filer affirms no undisclosed material information and notes Rule 144 compliance; if a 10b5-1 plan exists it would formalize planned sales, reducing signaling risk.

Corporate Governance Expert

TL;DR: Procedural disclosure aligns with standard insider selling and Rule 144 requirements.

The Form 144 provides required broker, amount, and acquisition history details for the proposed sale. The separate acquisition entries from 2022–2024 show the shares originated from restricted stock grants, a common executive compensation mechanism. The absence of sales in the prior three months and the filer’s representation about material information are important governance elements that support transparency. Overall, the filing reads as a standard, compliant disclosure rather than a governance red flag.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	34568	266190.88	187096094	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/03/2022	Restricted Stock	Issuer			5620	11/03/2022	Not Applicable
Common	11/03/2023	Restricted Stock	Issuer			8565	11/03/2023	Not Applicable
Common	11/03/2024	Restricted Stock	Issuer			8565	11/03/2024	Not Applicable
Common	05/21/2024	Restricted Stock	Issuer			11818	05/21/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does N-able's (NABL) Form 144 disclose?

The notice discloses a proposed sale of 34,568 common shares via Morgan Stanley on the NYSE with an aggregate market value of $266,190.88.

When were the shares being sold originally acquired?

The shares were acquired as restricted stock on 11/03/2022, 11/03/2023, 11/03/2024, and 05/21/2024 according to the filing.

How large is the proposed sale relative to N-able's shares outstanding?

The company reports 187,096,094 shares outstanding; the proposed 34,568-share sale is a very small fraction of total outstanding shares.

Did the filer sell other N-able securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filing indicate compliance with Rule 144 or a 10b5-1 plan?

The notice references Rule 144 compliance and the filer represents they may have adopted a 10b5-1 trading plan or given trading instructions, if applicable.